Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prime Medicine (PRME) Non-Current Deferred Tax Liability: 2021-2022

Historic Non-Current Deferred Tax Liability for Prime Medicine (PRME) over the last 2 years, with Dec 2022 value amounting to $8.7 million.

  • Prime Medicine's Non-Current Deferred Tax Liability rose 74.03% to $134,000 in Q1 2024 from the same period last year, while for Mar 2024 it was $134,000, marking a year-over-year increase of 74.03%. This contributed to the annual value of $8.7 million for FY2022, which is 46.57% up from last year.
  • Latest data reveals that Prime Medicine reported Non-Current Deferred Tax Liability of $8.7 million as of FY2022, which was up 46.57% from $6.0 million recorded in FY2021.
  • Over the past 5 years, Prime Medicine's Non-Current Deferred Tax Liability peaked at $8.7 million during FY2022, and registered a low of $6.0 million during FY2021.
  • Its 2-year average for Non-Current Deferred Tax Liability is $7.4 million, with a median of $7.4 million in 2021.
  • Data for Prime Medicine's Non-Current Deferred Tax Liability shows a peak YoY skyrocketed of 46.57% (in 2022) over the last 5 years.
  • Over the past 2 years, Prime Medicine's Non-Current Deferred Tax Liability (Yearly) stood at $6.0 million in 2021, then soared by 46.57% to $8.7 million in 2022.